产品发布 - BioHarvest Sciences推出Vinia产品线新成员"2X formula"咀嚼片 专为运动员和高活跃度消费者设计 [1] - 新产品每片含12mg白藜芦醇苷(Piceid Resveratrol) 是原胶囊剂型(6mg)的两倍剂量 [1][5] - 产品通过Informed Sport认证 检测超过500种物质 符合全球反兴奋剂标准 [6][7] 产品开发背景 - 产品灵感来自两年前与NFL联合训练营运动员的合作 发现需要两粒胶囊剂量才能产生明显效果 [5] - 每片仅含15卡路里 具有良好口感且便于携带 满足高强度运动人群需求 [6] - 认证需求不仅来自职业运动员 业余运动员和军方也要求第三方验证 [7] 市场策略 - 采用"Vinia inside"战略 结合植物合成技术优势 临床验证效果和盲测确认口感 [9] - 针对不同生命周期阶段开发产品 从运动员到老年消费者全覆盖 [10] - 未来120天内将推出针对160亿美元美国补水市场的新产品Vinia Blood Flow Hydration [10] 产品线扩展 - Vinia产品线已从胶囊扩展到咀嚼片 茶饮和咖啡等多种形态 [9] - 新产品预计将带来增量收入和客户增长 类似胶囊产品在老年人群的成功 [8] - 所有产品均提供改善动脉舒张和血流等健康益处 [10]

Informed Sport is the world's leading testing and certification program for brands producing sports and nutritional supplements. Designed for elite sport, it protects athletes from inadvertent doping caused by supplements contaminated with banned substances. As such, it is recognised by sporting and governing bodies, anti-doping bodies and nutrition industry organisations, and the armed and special forces. https://sport.wetestyoutrust.com/ BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X For ...

BioHarvest Sciences Inc. (NASDAQ:BHST) earlier this week announced a new contract targeting the plant-based fragrance compound market, using its proprietary botanical synthesis platform. CEO Ilan Sobel said the contract focuses on a rare plant under threat from overharvesting and habitat loss. BioHarvest highlighted that the market for natural, plant-derived fragrance ingredients is growing in response to increasing consumer awareness. Proactive: Joining me now is Ilan Sobel. He is the CEO of BioHarvest Sci ...

核心观点 - BioHarvest Sciences Inc 宣布其植物合成CDMO服务部门获得新合同 开发一种因过度采伐和栖息地丧失而受到严重威胁的植物基香料化合物 目标市场为价值数十亿美元的香料和气味市场 [1] - 这是公司首次在CDMO项目中使用内部AI工具发现植物细胞靶点 用于植物合成过程 [1] - 该合同采用分阶段付款结构 第一阶段利用公司专有植物合成平台在培养皿中复制、放大和繁殖目标植物细胞 成功后将进入第二阶段 涉及液体培养基中的化合物生产 [2][3] - 该协议标志着公司进入全球香料和气味市场的第一步 展示了其平台在新垂直领域的多功能性 [3][4] 合同细节 - 合同第一阶段已利用AI辅助研究能力确定最有可能开发成所需细胞库的特定植物物种 [2] - 合同包含保密协议 采用基于里程碑的付款结构 [3] - 成功商业化这些香料化合物可能代表植物产品生产方式的突破 [4] 公司战略与平台 - 植物合成技术平台已成熟为变革性技术 重塑获取最有价值植物基化合物的途径 [4] - 平台在两个主要业务垂直领域发展下一代科学基础和临床验证的治疗解决方案：作为CDMO为客户开发新型植物基化合物 以及开发专有保健品 [5][6] - 每个CDMO项目都加强了AI驱动的发现能力 [4] 市场机会 - 香料化合物驱动全球数十亿美元的销售额 [4] - 该合同验证了公司提供可扩展、高影响力跨行业解决方案的能力 同时有助于保护濒危稀有植物物种 [4]

BioHarvest Sciences (BHST) Q1 2025 Earnings Call May 15, 2025 04:30 PM ET Company Participants Ilan Sobel - CEOBar Dichter - CFONicholas Sherwood - Equity Research AssociateHunter Diamond - Owner Conference Call Participants Matt Hewitt - Senior Research AnalystAmit Dayal - Managing Director & Senior Technology AnalystSusan Anderson - Managing Director & Senior Analyst Operator Greetings, and welcome to the BioHarvest Sciences First Quarter twenty twenty five Corporate Update Conference Call. At this time, ...

BioHarvest Sciences (BHST) Q1 2025 Earnings Call May 15, 2025 04:30 PM ET Speaker0 Greetings, and welcome to the BioHarvest Sciences First Quarter twenty twenty five Corporate Update Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. Before we begin the formal presentation, I'd like to remind everyone that statements made on today's call and webcast, including those re ...

BioHarvest Sciences Reports First Quarter 2025 Financial ResultsFirst Quarter Revenues Grew 47% to $7.9 Million, Exceeding Management GuidanceMay 15, 2025 4:05 PM EDT | Source: BioHarvest Sciences Inc.Rehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the first quarter ended March ...